SEC Form D · filed July 27, 2020
Tallac Therapeutics, Inc
Industry
Other Health Care
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (18)
Mark Swanson · Tampa, FLDirectorJaume Pons · Burlingame, CADirectorAndrew Menlove · SALT LAKE CITY, UTDirectorGreg Moritz · Marietta, GADirectorShreyans Jain · Frisco, TXExec · DirectorIsaac Cheng · Burlingame, CADirectorWeston Reynolds · New York, NYDirectorChristopher Rising · Los Angeles, CADirectorJonathan Davila · Tampa, FLExec · DirectorChristine Brennan · Burlingame, CADirectorMatthew Leyrer · Dallas, TXDirectorMichael Carusi · Burlingame, CADirectorScott Mcmullin · Los Angeles, CADirectorHong Wan · Burlingame, CAExec · DirectorCorey Goodman · Burlingame, CADirectorConnor Mclaughlin · NEW YORK, NYDirectorJosh Sharkey · Cortlandt Manor, NYDirectorTally Ringwood · SALT LAKE CITY, UTDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗